Αποτελέσματα Αναζήτησης
individuals with metabolic syndrome early, so that lifestyle interventions and treatment may prevent the development of diabetes and/or cardiovascular disease. A number of expert groups have developed clinical criteria for the metabolic syndrome. The most widely accepted of these were produced by the World Health Organization (WHO), the
The new IDF definition of metabolic syndrome in children and adolescents is inspired, in part, by the IDF world-wide definition of metabolic syndrome in adults.2 It builds on previous studies that used modified adult criteria to in-vestigate its prevalence in children and adolescents (see table 1). 4-18-19-20-21 The wide variety of cut-off points
The IDF has produced a new set of criteria for use both epidemio-logically and in clinical practice world-wide with the aim of identifying people with the MetS to clarify the nature of the syndrome and to focus therapeutic strategies to reduce the long-term risk of cardiovascular disease. Guidance is
metabolic syndrome Part 1: Worldwide definition for use in clinical practice Table 1: The new International Diabetes Federation (IDF) definition According to the new IDF definition, for a person to be defined as having the metabolic syndrome they must have: Central obesity (defined as waist circumference ≥ 94cm for Europid men and ≥ 80cm
Metabolic syndrome (MetS) and its components increase the risk of developing cardiovascular diseases, type 2 diabetes, and all-cause mortality. Reports on the trends of MetS and its components in longitudinal studies are scarce, especially in low- and middle-income countries.
Totally, 1802 people (735 men and 1067 women) with metabolic syndrome were surveyed according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the International Diabetes Federation (IDF) criteria as well as obtained WC cut-off points for IDF criteria.
The aim of this study was to determine the prevalence of metabolic syndrome according to the three criteria of ATPIII, IDF and the new criteria for metabolic syndrome diagnosis in Kerman, Iran. This cross-sectional study was performed on 950 diabetic type 2 patients.
